A 52-year-old man with GERD is started on omeprazole 20 mg daily. After 3 days, he reports minimal symptom relief. His colleague, who takes famotidine 20 mg twice daily, reports complete relief within 1 hour of the first dose. Which pharmacokinetic feature explains why the PPI-treated patient must wait longer for symptom relief despite superior acid suppression?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.